Mammazentrum Hamburg MVZ GbR
Hamburg 20357
2 studies enrolling now · 2 studies all time
What they study most
Breast Cancer
Studies at this site
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
— Recruiting now
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
— Recruiting now